Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Arcturus Therapeutics Holdings Inc. (ARCT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Arcturus Therapeutics and Cystic Fibrosis Foundation Extend Agreement to Advance ARCT-032, an Investigational Messenger RNA Therapeutic to Treat Cystic Fibrosis"
08/14/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government"
08/07/2023 8-K Quarterly results
Docs: "ARCTURUS THERAPEUTICS HOLDINGS INC. AMENDMENT NO. 1 TO Controlled Equity Offering SM Sales Agreement August 7, 2023 CANTOR FITZGERALD & CO. 499 Park Avenue 10022 WELLS FARGO SECURITIES, LLC 30 Hudson Yards New York, New York 10001 William Blair & Company, L.L.C.",
"Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress"
07/14/2023 8-K Regulation FD Disclosure  Interactive Data
06/30/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan"
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 8-K Quarterly results
Docs: "Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress"
04/28/2023 8-K Quarterly results
04/21/2023 8-K Quarterly results
03/28/2023 8-K Quarterly results
03/17/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
12/13/2022 8-K Quarterly results
12/13/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
09/01/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of Self-amplifying mRNA Vaccine for Rapid Pandemic Influenza Response · Arcturus will expand its current influenza vaccine program to include development of a pandemic influenza vaccine based on its proprietary self-amplifying mRNA platform with the support of the Biomedical Advanced Research and Development Authority. · The $63.2 Million base award will fund development from the preclinical stage through Phase 1 over a three-year period. · A lower-dose, freeze-dried, pandemic influenza vaccine candidate will use Arcturus’ STARR™ self-amplifying mRNA vaccine platform technology which demonstrated favorable safety and efficacy against SARS-CoV-2 infection combined with a stable ..."
08/09/2022 8-K Quarterly results
Docs: "Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress"
06/24/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
04/20/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study"
02/28/2022 8-K Quarterly results
02/17/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/11/2022 8-K Quarterly results
01/11/2022 8-K Regulation FD Disclosure  Interactive Data
12/13/2021 8-K Quarterly results
11/08/2021 8-K Quarterly results
Docs: "Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress"
11/01/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
10/05/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/26/2021 8-K Termination of a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointmen...
08/09/2021 8-K Quarterly results
08/04/2021 8-K Quarterly results
06/22/2021 8-K Quarterly results
05/10/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy